Doherty researchers develop world-first AMR detection tool 

  23 February 2023

A new tool that could soon revolutionise the way we identify antimicrobial resistance (AMR) has been developed by researchers at the University of Melbourne’s Microbiological Diagnostic Unit Public Health Laboratory (MDU PHL), located at the Peter Doherty Institute for Infection and Immunity (Doherty Institute).

abritAMR is an ISO-certified bioinformatics platform that is able to find AMR determinants from whole genome sequencing data and separates the identified genes into functionally relevant groups. 

To date, the lack of international standards in the AMR genomics space has been a limiting factor in the ability to compare outputs from different laboratories, especially with regards to how that information is applied in the clinical context.

Further reading: Doherty Institute
Author(s): Doherty Institute
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Ambassador Network

Join the AMR Insights Ambassador Network today!

Connect to over 650 AMR professionals and students in 65 countries!

More information

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed